Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01057433 · ClinicalTrials.gov registry record · Phase 4
Drug-Drug Interaction of Lopinavir/Ritonavir on Pitavastatin
A Phase 4 study, sponsored by Kowa Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT01057433: Completed Phase 4 study, sponsored by Kowa Research Institute.
NCT01057433 is a Phase 4 study that has completed, run by Kowa Research Institute. The registered enrollment target is 24 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01057433, a Phase 4 study, has completed, sponsored by Kowa Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
This is a Phase 4, single center, open label, fixed-sequence, 2-way drug-drug interaction study.
Primary Outcome
Area under the curve from start to elimination.
Interventions
- DRUG Lopinavir/ritonavir
- DRUG Pitavastatin (NK-104)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2010-01 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
What the finished NCT01057433 record still lists
NCT01057433 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Lopinavir/ritonavir is the first listed.
NCT01057433 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01057433 about?
NCT01057433 is a clinical study titled "Drug-Drug Interaction of Lopinavir/Ritonavir on Pitavastatin". This is a Phase 4, single center, open label, fixed-sequence, 2-way drug-drug interaction study.
What is the current status of trial NCT01057433?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2010-01. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01057433?
The interventions under investigation include: Lopinavir/ritonavir (DRUG), Pitavastatin (NK-104) (DRUG).
Who is sponsoring clinical trial NCT01057433?
This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01057433's enrollment target sits among peer trials
24 1699th of 2000 higher than 276 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia